ArticleDiscover oncology2025

F-α-DDB-derivative, a novel synthetic of bifendate, plus epirubicin improves antitumor efficacy against triple negative breast cancer without additional cardiotoxicity.

Hai-Yi Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.